Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Regencell Bioscience Holdings Ltd as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q2 2025
- Shares held
- 633.8K
- −57.9K (−8.4%) vs. Q2 2025
- Total value
- $9.79M
- −$2.00M (−16.9%) vs. Q2 2025
- New holders
- 7
- 4 more added
- Sold out
- 5
- 5 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $8.56M |
| Q1 2026 | 31 | $16.5M |
| Q4 2025 | 17 | $11.5M |
| Q3 2025 | 16 | $9.79M |
| Q2 2025 | 14 | $11.8M |
| Q1 2025 | 5 | $281.3K |
| Q4 2024 | 3 | $155.9K |
| Q3 2024 | 2 | $100.4K |
| Q2 2024 | 3 | $1.89K |
| Q1 2024 | 3 | $7.43K |
| Q4 2023 | 3 | $171.2K |
| Q3 2023 | 4 | $9.27K |
| Q2 2023 | 2 | $11.7K |
| Q1 2023 | 4 | $18.9K |
| Q4 2022 | 3 | $32.3K |
| Q3 2022 | 5 | $260.0K |
| Q2 2022 | 5 | $296.0K |
| Q1 2022 | 5 | $434.0K |
| Q4 2021 | 2 | $230.0K |
| Q3 2021 | 3 | $316.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Regencell Bioscience Holdings Ltd; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 419,970 | $6.49M | 0.00% | +28,904+7.4% | Added |
| Squarepoint Ops LLC | 51,249 | $791.8K | 0.00% | −48,594−48.7% | Reduced |
| Discovery Capital Management, LLC | 46,166 | $713.3K | 0.04% | +46,166 | New |
| XTX Topco Ltd | 38,735 | $598.5K | 0.03% | +38,735 | New |
| Morgan Stanley | 37,842 | $584.7K | 0.00% | +4,822+14.6% | Added |
| Vident Advisory, LLC | 18,068 | $279.2K | 0.00% | +18,068 | New |
| Jane Street Group, LLC | 10,616 | $164.0K | 0.00% | +10,616 | New |
| BlackRock, Inc. | 4,865 | $75.2K | 0.00% | −3,724−43.4% | Reduced |
| BNP Paribas Arbitrage, SA | 4,682 | $72.3K | 0.00% | −40,368−89.6% | Reduced |
| UBS Group AG | 380 | $5.87K | 0.00% | −37,147−99.0% | Reduced |
| Tower Research Capital LLC (TRC) | 357 | $5.52K | 0.00% | +357 | New |
| Farther Finance Advisors, LLC | 322 | $4.97K | 0.00% | +272+544.0% | Added |
| Advisor Group Holdings, Inc. | 227 | $3.27K | 0.00% | +37+19.5% | Added |
| Simplex Trading, LLC | 217 | $3.00K | 0.00% | +217 | New |
| Group One Trading, L.P. | 100 | $1.54K | 0.00% | +100 | New |
| Bank of America Corp | 15 | $232 | 0.00% | −85−85.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −52,100−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −13,042−100.0% | Sold out |
| Greenfield Savings Bank | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −70−100.0% | Sold out |